HOME › DRUGS › REVEFENACIN
ACTIVE SUBSTANCE / INN

REVEFENACIN

Brand name(s): YUPELRI, REVEFENACIN
FDA LISTED
PRESCRIPTION
NONE (TENTATIVE APPROVAL)
ANDA218089
NDA210598
ACTIVE SUBSTANCE
Revefenacin
REGULATORS
FDA
SPONSORS / MAH
MYLAN IRELAND LTD, MANKIND PHARMA LTD
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
YUPELRINDA210598MYLAN IRELAND LTDPrescription
REVEFENACINANDA218089MANKIND PHARMA LTDNone (Tentative Approval)

FULL INTELLIGENCE ON REVEFENACIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →